is tirzepatide a glp-1 receptor agonist Tirzepatide, dual GIP/GLP-1 co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction | Cardiovascular Diabetology Tirzepatide (Mounjaro/Zepbound): Research Guide |
Pay in 4 interest-free payments of $5.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




















![3rd GLP-1-Based Therapeutics Summit 2026 [04/14/26]](https://media.thebostoncalendar.com/images/q_auto,fl_lossy/v1764586403/xfhrsgzqsy7gc1nv7hdi/3rd-glp-1-based-therapeutics-summit-2026.jpg)






